Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 74 entries
Sorted by: Best Match Show Resources per page
Comparison of angiographic aspects and anatomical lesions of coronary arteries.

Archives des maladies du coeur et des vaisseaux

Fournier C, Barrillon A, Paraiso N, Saudemont JP, Gerbaux A.
PMID: 816315
Arch Mal Coeur Vaiss. 1975 Jul;68(7):691-8.

The coronary angiograms of 32 patients were compared with the anatomical lesions found during the postmortem examinations which were done early after the X-ray examination. The angiographic and anatomical data coincided in 81.6 per cent of all the coronary...

Cite
Fournier C, Barrillon A, Paraiso N, et al. Comparaison entre les aspects angiographiques et les lésions anatomiques des artéres coronaires Comparison of angiographic aspects and anatomical lesions of coronary arteries. Arch Mal Coeur Vaiss. 1975;68(7):691-8
Fournier, C., Barrillon, A., Paraiso, N., Saudemont, J. P., & Gerbaux, A. (1975). Comparaison entre les aspects angiographiques et les lésions anatomiques des artéres coronaires Comparison of angiographic aspects and anatomical lesions of coronary arteries. Archives des maladies du coeur et des vaisseaux, 68(7), 691-8.
Fournier, C, et al. "Comparaison entre les aspects angiographiques et les lésions anatomiques des artéres coronaires" Comparison of angiographic aspects and anatomical lesions of coronary arteries. Archives des maladies du coeur et des vaisseaux vol. 68,7 (1975): 691-8.
Fournier C, Barrillon A, Paraiso N, Saudemont JP, Gerbaux A. Comparaison entre les aspects angiographiques et les lésions anatomiques des artéres coronaires Comparison of angiographic aspects and anatomical lesions of coronary arteries. Arch Mal Coeur Vaiss. 1975 Jul;68(7):691-8. French. PMID: 816315.
Copy Download .nbib Format: NLM
Minimal Window Duration for Accurate HRV Recording in Athletes.

Frontiers in neuroscience

Bourdillon N, Schmitt L, Yazdani S, Vesin JM, Millet GP.
PMID: 28848382
Front Neurosci. 2017 Aug 10;11:456. doi: 10.3389/fnins.2017.00456. eCollection 2017.

Heart rate variability (HRV) is non-invasive and commonly used for monitoring responses to training loads, fitness, or overreaching in athletes. Yet, the recording duration for a series of RR-intervals varies from 1 to 15 min in the literature. The...

Cite
Bourdillon N, Schmitt L, Yazdani S, et al. Minimal Window Duration for Accurate HRV Recording in Athletes. Front Neurosci. 2017;11:456doi: 10.3389/fnins.2017.00456.
Bourdillon, N., Schmitt, L., Yazdani, S., Vesin, J. M., & Millet, G. P. (2017). Minimal Window Duration for Accurate HRV Recording in Athletes. Frontiers in neuroscience, 11456. https://doi.org/10.3389/fnins.2017.00456
Bourdillon, Nicolas, et al. "Minimal Window Duration for Accurate HRV Recording in Athletes." Frontiers in neuroscience vol. 11 (2017): 456. doi: https://doi.org/10.3389/fnins.2017.00456
Bourdillon N, Schmitt L, Yazdani S, Vesin JM, Millet GP. Minimal Window Duration for Accurate HRV Recording in Athletes. Front Neurosci. 2017 Aug 10;11:456. doi: 10.3389/fnins.2017.00456. eCollection 2017. PMID: 28848382; PMCID: PMC5554345.
Copy Download .nbib Format: NLM
Transient neonatal renal failure and massive polyuria in MEGDEL syndrome.

Molecular genetics and metabolism reports

Harbulot C, Paquay S, Dorboz I, Pichard S, Bourillon A, Benoist JF, Jardel C, Ogier de Baulny H, Boespflug-Tanguy O, Schiff M.
PMID: 27331002
Mol Genet Metab Rep. 2016 Mar 10;7:8-10. doi: 10.1016/j.ymgmr.2016.03.001. eCollection 2016 Jun.

BACKGROUND: MEGDEL (3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome) syndrome is a mitochondrial disorder associated with recessive mutations in SERAC1.OBJECTIVES: To report transient neonatal renal findings in MEGDEL syndrome.RESULTS: This 7 year-old girl was the first child of...

Cite
Harbulot C, Paquay S, Dorboz I, et al. Transient neonatal renal failure and massive polyuria in MEGDEL syndrome. Mol Genet Metab Rep. 2016;7:8-10doi: 10.1016/j.ymgmr.2016.03.001.
Harbulot, C., Paquay, S., Dorboz, I., Pichard, S., Bourillon, A., Benoist, J. F., Jardel, C., Ogier de Baulny, H., Boespflug-Tanguy, O., & Schiff, M. (2016). Transient neonatal renal failure and massive polyuria in MEGDEL syndrome. Molecular genetics and metabolism reports, 78-10. https://doi.org/10.1016/j.ymgmr.2016.03.001
Harbulot, Carole, et al. "Transient neonatal renal failure and massive polyuria in MEGDEL syndrome." Molecular genetics and metabolism reports vol. 7 (2016): 8-10. doi: https://doi.org/10.1016/j.ymgmr.2016.03.001
Harbulot C, Paquay S, Dorboz I, Pichard S, Bourillon A, Benoist JF, Jardel C, Ogier de Baulny H, Boespflug-Tanguy O, Schiff M. Transient neonatal renal failure and massive polyuria in MEGDEL syndrome. Mol Genet Metab Rep. 2016 Mar 10;7:8-10. doi: 10.1016/j.ymgmr.2016.03.001. eCollection 2016 Jun. PMID: 27331002; PMCID: PMC4908062.
Copy Download .nbib Format: NLM
2-(6-bromopyridin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and (6-bromopyridin-3-yl)boronic acid, new bifunctional building blocks for combinatorial chemistry.

Acta crystallographica. Section C, Crystal structure communications

Sopková-de Oliveira Santos J, Lancelot JC, Bouillon A, Rault S.
PMID: 12711779
Acta Crystallogr C. 2003 Mar;59:o111-3. doi: 10.1107/s0108270103000908. Epub 2003 Feb 11.

The first comparative study between two new heterocyclic boron derivatives, viz. a (6-bromopyridin-3-yl)boronic ester, C(11)H(15)BBrNO(2), and (6-bromopyridin-3-yl)boronic acid, C(5)H(5)BBrNO(2), shows a small but not significant difference in their C-B bond lengths, which cannot explain the experimentally observed difference in...

Cite
Sopková-de Oliveira Santos J, Lancelot JC, Bouillon A, et al. 2-(6-bromopyridin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and (6-bromopyridin-3-yl)boronic acid, new bifunctional building blocks for combinatorial chemistry. Acta Crystallogr C. 2003;59:o111-3doi: 10.1107/s0108270103000908.
Sopková-de Oliveira Santos, J., Lancelot, J. C., Bouillon, A., & Rault, S. (2003). 2-(6-bromopyridin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and (6-bromopyridin-3-yl)boronic acid, new bifunctional building blocks for combinatorial chemistry. Acta crystallographica. Section C, Crystal structure communications, 59o111-3. https://doi.org/10.1107/s0108270103000908
Sopková-de Oliveira Santos, Jana, et al. "2-(6-bromopyridin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and (6-bromopyridin-3-yl)boronic acid, new bifunctional building blocks for combinatorial chemistry." Acta crystallographica. Section C, Crystal structure communications vol. 59 (2003): o111-3. doi: https://doi.org/10.1107/s0108270103000908
Sopková-de Oliveira Santos J, Lancelot JC, Bouillon A, Rault S. 2-(6-bromopyridin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and (6-bromopyridin-3-yl)boronic acid, new bifunctional building blocks for combinatorial chemistry. Acta Crystallogr C. 2003 Mar;59:o111-3. doi: 10.1107/s0108270103000908. Epub 2003 Feb 11. PMID: 12711779.
Copy Download .nbib Format: NLM
THE VOLUME OF THE EXTRACELLULAR FLUIDS OF THE BODY.

The Journal of clinical investigation

Lavietes PH, Bourdillon J, Klinghoffer KA.
PMID: 16694397
J Clin Invest. 1936 May;15(3):261-8. doi: 10.1172/JCI100775.

No abstract available.

Cite
Lavietes PH, Bourdillon J, Klinghoffer KA. THE VOLUME OF THE EXTRACELLULAR FLUIDS OF THE BODY. J Clin Invest. 1936;15(3):261-8doi: 10.1172/JCI100775.
Lavietes, P. H., Bourdillon, J., & Klinghoffer, K. A. (1936). THE VOLUME OF THE EXTRACELLULAR FLUIDS OF THE BODY. The Journal of clinical investigation, 15(3), 261-8. https://doi.org/10.1172/JCI100775
Lavietes, P H, et al. "THE VOLUME OF THE EXTRACELLULAR FLUIDS OF THE BODY." The Journal of clinical investigation vol. 15,3 (1936): 261-8. doi: https://doi.org/10.1172/JCI100775
Lavietes PH, Bourdillon J, Klinghoffer KA. THE VOLUME OF THE EXTRACELLULAR FLUIDS OF THE BODY. J Clin Invest. 1936 May;15(3):261-8. doi: 10.1172/JCI100775. PMID: 16694397; PMCID: PMC424783.
Copy Download .nbib Format: NLM
Displacement of equilibrium in electroenzymatic reactor for acetaldehyde production using yeast alcohol dehydrogenase.

Biotechnology and bioengineering

Lortie R, Fassouane A, Laval JM, Bourdillon C.
PMID: 18600926
Biotechnol Bioeng. 1992 Jan 20;39(2):157-63. doi: 10.1002/bit.260390206.

Electrochemical regeneration of NAD was performed in a bench scale reactor in which yeast alcohol dehydrogenase catalyzed the oxidation of ethanol. By recycling one of the products of the reaction, it was possible to displace the equilibrium and favor...

Cite
Lortie R, Fassouane A, Laval JM, et al. Displacement of equilibrium in electroenzymatic reactor for acetaldehyde production using yeast alcohol dehydrogenase. Biotechnol Bioeng. 1992;39(2):157-63doi: 10.1002/bit.260390206.
Lortie, R., Fassouane, A., Laval, J. M., & Bourdillon, C. (1992). Displacement of equilibrium in electroenzymatic reactor for acetaldehyde production using yeast alcohol dehydrogenase. Biotechnology and bioengineering, 39(2), 157-63. https://doi.org/10.1002/bit.260390206
Lortie, R, et al. "Displacement of equilibrium in electroenzymatic reactor for acetaldehyde production using yeast alcohol dehydrogenase." Biotechnology and bioengineering vol. 39,2 (1992): 157-63. doi: https://doi.org/10.1002/bit.260390206
Lortie R, Fassouane A, Laval JM, Bourdillon C. Displacement of equilibrium in electroenzymatic reactor for acetaldehyde production using yeast alcohol dehydrogenase. Biotechnol Bioeng. 1992 Jan 20;39(2):157-63. doi: 10.1002/bit.260390206. PMID: 18600926.
Copy Download .nbib Format: NLM
Electrochemical regeneration of NAD in a plug-flow reactor.

Biotechnology and bioengineering

Fassouane A, Laval JM, Moiroux J, Bourdillon C.
PMID: 18592598
Biotechnol Bioeng. 1990 Apr 15;35(9):935-9. doi: 10.1002/bit.260350911.

Electrochemical regeneration of NAD was performed at a laboratory preparative scale to illustrate both the efficiency and intrinsic simplicity of the electrochemical method. A powerful plug-flow reactor was realized with a flow through graphite felt electrode, the ratio of...

Cite
Fassouane A, Laval JM, Moiroux J, et al. Electrochemical regeneration of NAD in a plug-flow reactor. Biotechnol Bioeng. 1990;35(9):935-9doi: 10.1002/bit.260350911.
Fassouane, A., Laval, J. M., Moiroux, J., & Bourdillon, C. (1990). Electrochemical regeneration of NAD in a plug-flow reactor. Biotechnology and bioengineering, 35(9), 935-9. https://doi.org/10.1002/bit.260350911
Fassouane, A, et al. "Electrochemical regeneration of NAD in a plug-flow reactor." Biotechnology and bioengineering vol. 35,9 (1990): 935-9. doi: https://doi.org/10.1002/bit.260350911
Fassouane A, Laval JM, Moiroux J, Bourdillon C. Electrochemical regeneration of NAD in a plug-flow reactor. Biotechnol Bioeng. 1990 Apr 15;35(9):935-9. doi: 10.1002/bit.260350911. PMID: 18592598.
Copy Download .nbib Format: NLM
Localized reduction of graphene oxide by electrogenerated naphthalene radical anions and subsequent diazonium electrografting.

Journal of the American Chemical Society

Azevedo J, Fillaud L, Bourdillon C, Noël JM, Kanoufi F, Jousselme B, Derycke V, Campidelli S, Cornut R.
PMID: 24628490
J Am Chem Soc. 2014 Apr 02;136(13):4833-6. doi: 10.1021/ja500189u. Epub 2014 Mar 18.

Herein, we describe a new localized functionalization method of graphene oxide (GO) deposited on a silicon oxide surface. The functionalization starts with the reduction of GO by electrogenerated naphthalene radical anions. The source of reducers is a microelectrode moving...

Cite
Azevedo J, Fillaud L, Bourdillon C, et al. Localized reduction of graphene oxide by electrogenerated naphthalene radical anions and subsequent diazonium electrografting. J Am Chem Soc. 2014;136(13):4833-6doi: 10.1021/ja500189u.
Azevedo, J., Fillaud, L., Bourdillon, C., Noël, J. M., Kanoufi, F., Jousselme, B., Derycke, V., Campidelli, S., & Cornut, R. (2014). Localized reduction of graphene oxide by electrogenerated naphthalene radical anions and subsequent diazonium electrografting. Journal of the American Chemical Society, 136(13), 4833-6. https://doi.org/10.1021/ja500189u
Azevedo, Joël, et al. "Localized reduction of graphene oxide by electrogenerated naphthalene radical anions and subsequent diazonium electrografting." Journal of the American Chemical Society vol. 136,13 (2014): 4833-6. doi: https://doi.org/10.1021/ja500189u
Azevedo J, Fillaud L, Bourdillon C, Noël JM, Kanoufi F, Jousselme B, Derycke V, Campidelli S, Cornut R. Localized reduction of graphene oxide by electrogenerated naphthalene radical anions and subsequent diazonium electrografting. J Am Chem Soc. 2014 Apr 02;136(13):4833-6. doi: 10.1021/ja500189u. Epub 2014 Mar 18. PMID: 24628490.
Copy Download .nbib Format: NLM
Electromagnetic Brain Stimulation in Patients With Disorders of Consciousness.

Frontiers in neuroscience

Bourdillon P, Hermann B, Sitt JD, Naccache L.
PMID: 30936822
Front Neurosci. 2019 Mar 18;13:223. doi: 10.3389/fnins.2019.00223. eCollection 2019.

Severe brain injury is a common cause of coma. In some cases, despite vigilance improvement, disorders of consciousness (DoC) persist. Several states of impaired consciousness have been defined, according to whether the patient exhibits only reflexive behaviors as in...

Cite
Bourdillon P, Hermann B, Sitt JD, et al. Electromagnetic Brain Stimulation in Patients With Disorders of Consciousness. Front Neurosci. 2019;13:223doi: 10.3389/fnins.2019.00223.
Bourdillon, P., Hermann, B., Sitt, J. D., & Naccache, L. (2019). Electromagnetic Brain Stimulation in Patients With Disorders of Consciousness. Frontiers in neuroscience, 13223. https://doi.org/10.3389/fnins.2019.00223
Bourdillon, Pierre, et al. "Electromagnetic Brain Stimulation in Patients With Disorders of Consciousness." Frontiers in neuroscience vol. 13 (2019): 223. doi: https://doi.org/10.3389/fnins.2019.00223
Bourdillon P, Hermann B, Sitt JD, Naccache L. Electromagnetic Brain Stimulation in Patients With Disorders of Consciousness. Front Neurosci. 2019 Mar 18;13:223. doi: 10.3389/fnins.2019.00223. eCollection 2019. PMID: 30936822; PMCID: PMC6432925.
Copy Download .nbib Format: NLM
[How to differentiate between useful and useless drugs?].

La Revue du praticien

Bergmann JF, Thervet E, Timsit J, Blacher J, Varet B, Hartemann A, Chosidow O, Mariette X, Gervais A, Amoura Z, Bruckert E, Pariente A, Vernant JP, Penformis F, Dautzenberg B, Sobel A, Guillevin L, Valla D, Leblond V, Gaudric A, Chast F, Bourdillon F, Fredenrich A, Bourgeois P, Grimaldi A.
PMID: 23272464
Rev Prat. 2012 Nov;62(9):1192-5.

No abstract available.

Cite
Bergmann JF, Thervet E, Timsit J, et al. Comment différencier les médicaments utiles et inutiles. [How to differentiate between useful and useless drugs?]. Rev Prat. 2012;62(9):1192-5
Bergmann, J. F., Thervet, E., Timsit, J., Blacher, J., Varet, B., Hartemann, A., Chosidow, O., Mariette, X., Gervais, A., Amoura, Z., Bruckert, E., Pariente, A., Vernant, J. P., Penformis, F., Dautzenberg, B., Sobel, A., Guillevin, L., Valla, D., Leblond, V., Gaudric, A., Chast, F., Bourdillon, F., Fredenrich, A., Bourgeois, P., & Grimaldi, A. (2012). Comment différencier les médicaments utiles et inutiles. [How to differentiate between useful and useless drugs?]. La Revue du praticien, 62(9), 1192-5.
Bergmann, Jean-François, et al. "Comment différencier les médicaments utiles et inutiles." [How to differentiate between useful and useless drugs?]. La Revue du praticien vol. 62,9 (2012): 1192-5.
Bergmann JF, Thervet E, Timsit J, Blacher J, Varet B, Hartemann A, Chosidow O, Mariette X, Gervais A, Amoura Z, Bruckert E, Pariente A, Vernant JP, Penformis F, Dautzenberg B, Sobel A, Guillevin L, Valla D, Leblond V, Gaudric A, Chast F, Bourdillon F, Fredenrich A, Bourgeois P, Grimaldi A. Comment différencier les médicaments utiles et inutiles. [How to differentiate between useful and useless drugs?]. Rev Prat. 2012 Nov;62(9):1192-5. French. PMID: 23272464.
Copy Download .nbib Format: NLM
Live 3D imaging and mapping of shear stresses within tissues using incompressible elastic beads.

Development (Cambridge, England)

Souchaud A, Boutillon A, Charron G, Asnacios A, Nous C, David NB, Graner F, Gallet F.
PMID: 35029679
Development. 2022 Jan 14; doi: 10.1242/dev.199765. Epub 2022 Jan 14.

To investigate the role of mechanical constraints in morphogenesis and development, we develop a pipeline of techniques based on incompressible elastic sensors. These techniques combine the advantages of incompressible liquid droplets, which have been used as precise in situ...

Cite
Souchaud A, Boutillon A, Charron G, et al. Live 3D imaging and mapping of shear stresses within tissues using incompressible elastic beads. Development. 2022;doi: 10.1242/dev.199765.
Souchaud, A., Boutillon, A., Charron, G., Asnacios, A., Nous, C., David, N. B., Graner, F., & Gallet, F. (2022). Live 3D imaging and mapping of shear stresses within tissues using incompressible elastic beads. Development (Cambridge, England), . https://doi.org/10.1242/dev.199765
Souchaud, Alexandre, et al. "Live 3D imaging and mapping of shear stresses within tissues using incompressible elastic beads." Development (Cambridge, England) vol. (2022). doi: https://doi.org/10.1242/dev.199765
Souchaud A, Boutillon A, Charron G, Asnacios A, Nous C, David NB, Graner F, Gallet F. Live 3D imaging and mapping of shear stresses within tissues using incompressible elastic beads. Development. 2022 Jan 14; doi: 10.1242/dev.199765. Epub 2022 Jan 14. PMID: 35029679.
Copy Download .nbib Format: NLM
Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study.

Clinics and research in hepatology and gastroenterology

Gallois C, Bourillon C, Auclin E, Artru P, Lièvre A, Lecomte T, Locher C, Marthey L, Faroux R, Pernot S, Barret M, Taieb J.
PMID: 33662782
Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101603. doi: 10.1016/j.clinre.2020.101603. Epub 2021 Mar 02.

PURPOSE: We showed in a previous study that the PG-SGA score is associated with survival and chemotherapy-related toxicities in metastatic colorectal cancer (mCRC) patients. The objective was to evaluate the association between pretherapeutic sarcopenia and variation in skeletal muscle...

Cite
Gallois C, Bourillon C, Auclin E, et al. Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study. Clin Res Hepatol Gastroenterol. 2021;45(6):101603doi: 10.1016/j.clinre.2020.101603.
Gallois, C., Bourillon, C., Auclin, E., Artru, P., Lièvre, A., Lecomte, T., Locher, C., Marthey, L., Faroux, R., Pernot, S., Barret, M., & Taieb, J. (2021). Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study. Clinics and research in hepatology and gastroenterology, 45(6), 101603. https://doi.org/10.1016/j.clinre.2020.101603
Gallois, Claire, et al. "Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study." Clinics and research in hepatology and gastroenterology vol. 45,6 (2021): 101603. doi: https://doi.org/10.1016/j.clinre.2020.101603
Gallois C, Bourillon C, Auclin E, Artru P, Lièvre A, Lecomte T, Locher C, Marthey L, Faroux R, Pernot S, Barret M, Taieb J. Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study. Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101603. doi: 10.1016/j.clinre.2020.101603. Epub 2021 Mar 02. PMID: 33662782.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 74 entries